HRT Stock Overview
Hurtimex SA designs, manufactures, and distributes clothing for children in Poland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Hurtimex SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.13 |
| 52 Week High | zł0.22 |
| 52 Week Low | zł0.12 |
| Beta | 0.99 |
| 1 Month Change | -8.90% |
| 3 Month Change | -25.28% |
| 1 Year Change | -26.11% |
| 3 Year Change | -54.45% |
| 5 Year Change | -44.12% |
| Change since IPO | -97.89% |
Recent News & Updates
Shareholder Returns
| HRT | PL Luxury | PL Market | |
|---|---|---|---|
| 7D | -13.6% | -2.8% | -0.7% |
| 1Y | -26.1% | 48.8% | 24.7% |
Return vs Industry: HRT underperformed the Polish Luxury industry which returned 48.8% over the past year.
Return vs Market: HRT underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
| HRT volatility | |
|---|---|
| HRT Average Weekly Movement | n/a |
| Luxury Industry Average Movement | 4.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.7% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: HRT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HRT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 29 | Jaroslaw Kopec | www.hurtimex.com.pl |
Hurtimex SA designs, manufactures, and distributes clothing for children in Poland and internationally. Its products include skirts, blouses, sweaters, handkerchiefs, and gloves. The company sells its products under the Tup Tup, KANZ, Döll, Lemmi, Pampolina, and Königsmühle brand names.
Hurtimex SA Fundamentals Summary
| HRT fundamental statistics | |
|---|---|
| Market cap | zł4.36m |
| Earnings (TTM) | zł143.11k |
| Revenue (TTM) | zł12.99m |
30.5x
P/E Ratio0.3x
P/S RatioIs HRT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HRT income statement (TTM) | |
|---|---|
| Revenue | zł12.99m |
| Cost of Revenue | zł8.71m |
| Gross Profit | zł4.28m |
| Other Expenses | zł4.14m |
| Earnings | zł143.11k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 0.0044 |
| Gross Margin | 32.98% |
| Net Profit Margin | 1.10% |
| Debt/Equity Ratio | 51.9% |
How did HRT perform over the long term?
See historical performance and comparison